Status:
TERMINATED
Does DNA Sperm Fragmentation Affects Embryo Morphokinetic?
Lead Sponsor:
IVI Madrid
Conditions:
Blastocyst Time
Pronuclear Appearance
Eligibility:
All Genders
36-38 years
Phase:
NA
Brief Summary
The embryokinetics may be a new prognostic factor for choosing the human embryos with the highest implantation potential. In order to identify the factors that may affect the rate of embryo cleavage, ...
Eligibility Criteria
Inclusion
- Patients 36 to 38 years
- Fresh sample semen
- Minimum 6 oocytes
- Semen sample with at least 5 million/ml and at least 30% of progressive motile sperm.
Exclusion
- Patients younger than 36 or older than 38 years old
- Frozen semen sample
- Less tan 6 oocytes.
- Semen samples with less than 5 million / ml or less than 30% of motile sperm.
Key Trial Info
Start Date :
February 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2018
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02214537
Start Date
February 1 2016
End Date
February 1 2018
Last Update
April 4 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IVI Madrid
Madrid, Spain, 28023